Cabot (NYSE:CBT) Issues Earnings Results

Cabot (NYSE:CBTGet Free Report) released its quarterly earnings data on Monday. The specialty chemicals company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.02, Zacks reports. Cabot had a return on equity of 26.60% and a net margin of 9.51%. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS.

Cabot Trading Up 4.0 %

NYSE CBT opened at $88.30 on Wednesday. The stock has a market capitalization of $4.79 billion, a price-to-earnings ratio of 13.10, a PEG ratio of 0.74 and a beta of 1.19. The stock’s 50 day moving average price is $94.83 and its two-hundred day moving average price is $101.99. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08. Cabot has a 52 week low of $70.63 and a 52 week high of $117.46.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be paid a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.95%. The ex-dividend date is Friday, February 28th. Cabot’s payout ratio is 25.52%.

Cabot announced that its board has approved a stock buyback plan on Tuesday, December 3rd that permits the company to repurchase 10,000,000 outstanding shares. This repurchase authorization permits the specialty chemicals company to buy shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. JPMorgan Chase & Co. cut Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price objective on the stock. in a report on Monday, November 11th. Mizuho cut their price objective on Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, Cabot presently has an average rating of “Hold” and an average price target of $102.00.

View Our Latest Stock Report on Cabot

Insider Buying and Selling at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 14,566 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $113.25, for a total transaction of $1,649,599.50. Following the transaction, the executive vice president now owns 69,449 shares of the company’s stock, valued at $7,865,099.25. The trade was a 17.34 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Lisa M. Dumont sold 865 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $111.74, for a total value of $96,655.10. Following the transaction, the chief accounting officer now directly owns 9,742 shares in the company, valued at $1,088,571.08. This trade represents a 8.15 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 50,190 shares of company stock worth $5,751,534. Corporate insiders own 3.03% of the company’s stock.

Cabot Company Profile

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.